Publication date: Available online 10 February 2018
Source:The Journal of Emergency Medicine
Author(s): Takahiro Shoji, Takehiko Tarui, Takashi Igarashi, Yuki Mochida, Hiroyuki Morinaga, Yasuhiko Miyakuni, Yoshitaka Inoue, Yasuhiko Kaita, Hiroshi Miyauchi, Yoshihiro Yamaguchi
BackgroundBleeding from hemorrhagic shock can be immediately controlled by blocking the proximal part of the hemorrhagic point using either resuscitative thoracotomy for aortic cross-clamping or insertion of a large-caliber (10–14Fr) resuscitative endovascular balloon occlusion of the aorta (REBOA) device via the femoral artery. However, such methods are very invasive and have various complications. With recent progress in endovascular treatment, a low-profile REBOA device (7Fr) has been developed.ObjectiveThe objective of this study was to report our experience of this low-profile REBOA device and to evaluate the usefulness of emergency physician−operated REBOA in life-threatening hemorrhagic shock.MethodsTen patients with refractory hemorrhagic shock underwent REBOA using this device via the femoral artery. All REBOA procedures were performed by emergency physicians. The success rate of the insertion, vital signs, and REBOA-related complications were evaluated.ResultsMedian age was 54 years (interquartile range 33–78 years). The causes of hemorrhagic shock were trauma (n = 4; 1 blunt and 3 penetrating), ruptured abdominal aortic aneurysm (n = 3), and obstetric hemorrhage (n = 3). Two patients had cardiopulmonary arrest upon arrival. REBOA procedure was successful in all patients, and all became hemodynamically stable to undergo definitive interventions after REBOA. There were no REBOA-related complications. The mortality rate within 24 h and 30 days was 40%.ConclusionsThis REBOA device was useful for emergency physicians in life-threatening hemorrhagic shock because of its ease in handling and low invasiveness.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2smL7PD
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract The incidences of thyroid cancer keep rising worldwide over the past few decades. Although most thyroid cancers are indolent and ...
-
Coexistence of t(5;17)/NPM1-RARA and t(9;22)/BCR-ABL1 in chronic myeloid leukemia at initial diagnosis Juvenile myelomonocytic leukemia: a s...
-
Abstract Background Hyponatremia is associated with the increased risk of early and late mortality in patients with cardiac disease. Thi...
-
Environmental tobacco smoke (ETS) is a potential cause of driver gene alterations. Using an extended multinational cohort of 498 never-smoke...
-
We set out to estimate net survival trends for 10 common cancers in 279 cancer registry populations in 67 countries around the world, as par...
-
Abstract Objectives Our aims were to examine the prevalence and genetic predictors of aspirin and clopidogrel high on-treatment platelet...
-
Abstract Amyloid beta peptide (Aβ), the main component of senile plaques of Alzheimer’s disease brains, is produced by sequential cleavage ...
-
Treatment satisfaction among men with concurrent benign prostatic hyperplasia and erectile dysfunction treated with tadalafil or other ...
-
Publication date: Available online 17 January 2018 Source: Journal of Infection and Chemotherapy Author(s): Nobuyasu Hirai, Kei Kasahara, ...
-
Background Epidemiology of Neisseria meningitidis has been changing since the introduction of universal vaccination programmes against meni...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου